The government’s Joint Committee on Vaccination and Immunisation (JCVI) has confirmed its priority list for the first phase of the UK’s mass vaccine rollout, which will begin early next week.
It comes after the UK became the first country in the world to approve the Pfizer/BioNTech COVID-19 vaccine for use.
Professor Lim, who is the chair of the JCVI, said age was the single most important factor in the estimated risk of mortality, and everyone in the country older than 50 will be vaccinated by the time the end of phase one.
Studies have shown the Pfizer jab is 95% effective and works in all age groups, and the government has secured 40 million doses of the vaccine, which needs to be refrigerated at -70C (-94F).
Ten million doses are expected in the UK by the end of the year. Although patients need two doses for the full effect, there is evidence of partial protection 12 days after the first dose.
According to Professor Sir Munir Pirmohamed, people who receive both vaccine doses would become completely immune seven days after their second dose.
Source: Sky News
HealthTrust Europe hold a strong and long-standing relationship with the NHS, and take a partnership approach to improve healthcare performance. They are committed to developing and delivering solutions that support the needs of public sector healthcare providers
Junction House, Waver Green, Leeds LS28 7BG
+44113 827 2347